By Syndicated Content
By Allison Martell and Euan Rocha
(Reuters) – To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.
As a result, the U.S. government laid claim not only to vast quantities of finished COVID-19 vaccines but also to vaccine components and equipment all along the supply chain, according to a Reuters review of more than a dozen contracts involving some major suppliers.
That has left some countries desperately in need of those supplies to scramble for substitutes, exacerbating international disparities in vaccine access, according to interviews with suppliers, foreign manufacturers and vaccine market experts.
Fri, 7th May 2021 16:00
By Allison Martell and Euan Rocha
May 7 (Reuters) - To fight the pandemic at home, the United
States gave its own vaccine manufacturers priority access to
American-made materials needed to make the shots.
As a result, the U.S. government laid claim not only to vast
quantities of finished COVID-19 vaccines but also to vaccine
components and equipment all along the supply chain, according
to a Reuters review of more than a dozen contracts involving
some major suppliers.
supplies to scramble for substitutes, exacerbating international
disparities in vaccine access, according to interviews with
suppliers, foreign manufacturers and vaccine market experts.
How the US locked up vaccine materials other nations urgently need
SECTIONS
Last Updated: May 07, 2021, 10:31 PM IST
Share
Synopsis
As a result, the U.S. government laid claim not only to vast quantities of finished COVID-19 vaccines but also to vaccine components and equipment all along the supply chain, according to a Reuters review of more than a dozen contracts involving some major suppliers.
Agencies
Countries ravaged by the virus - including India, where a catastrophic explosion of cases has filled hospitals and morgues - cannot make vaccines without such supplies, even with access to manufacturers cookbooks.
To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.